1. Home
  2. BLOG

BLOG

Researchers Find Way to Disrupt Cancer Stem Cell Growth That May Limit Mesothelioma Metastasis – MesotheliomaHelp.org (blog)

Continue reading

2016-02-04

Researchers Find Way to Disrupt Cancer Stem Cell Growth That May Limit Mesothelioma Metastasis
MesotheliomaHelp.org (blog)
A team of researchers from the Max Delbrück Center for Molecular Medicine (MDC) in Berlin, led by Liang Fang, report they have found a molecule that interrupts the stem cell survival mechanism, effectively killing off the cancer. The researchers report …
Continue reading

2016-02-04

Xconomy

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics
Xconomy
In a deal that consolidates its position as a leader in developing a stem cell-derived treatment for diabetes, San Diego’s ViaCyte says today it is absorbing its chief rival, New Jersey-based Janssen BetaLogics. The asset deal comes in conjunction with …
ViaCyte Acquires Rights to BetaLogics Assets, Expanding and Extending Industry-Leading Portfolio for Stem Cell …PR Newswire (press release)
Johnson & Johnson, ViaCyte Testing Possible Diabetes CureABC News
Possible diabetes cure being tested on small number of patientsQ13 FOX

all 47 news articles »
Continue reading

2016-02-04

Xconomy

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics
Xconomy
In a deal that consolidates its position as a leader in developing a stem cell-derived treatment for diabetes, San Diego’s ViaCyte says today it is absorbing its chief rival, New Jersey-based Janssen BetaLogics. The asset deal comes in conjunction with …
ViaCyte Acquires Rights to BetaLogics Assets, Expanding and Extending Industry-Leading Portfolio for Stem Cell …PR Newswire (press release)
Johnson & Johnson, ViaCyte Testing Possible Diabetes CureABC News

all 11 news articles »
Continue reading

2016-02-04

Xconomy

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics
Xconomy
In a deal that consolidates its position as a leader in developing a stem cell-derived treatment for diabetes, San Diego’s ViaCyte says today it is absorbing its chief rival, New Jersey-based Janssen BetaLogics. The asset deal comes in conjunction with …
ViaCyte Acquires Rights to BetaLogics Assets, Expanding and Extending Industry-Leading Portfolio for Stem Cell …PR Newswire (press release)
Johnson & Johnson, ViaCyte Testing Possible Diabetes CureABC News

all 11 news articles »
Continue reading

2016-02-04

Xconomy

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics
Xconomy
In a deal that consolidates its position as a leader in developing a stem cell-derived treatment for diabetes, San Diego’s ViaCyte says today it is absorbing its chief rival, New Jersey-based Janssen BetaLogics. The asset deal comes in conjunction with …
ViaCyte Acquires Rights to BetaLogics Assets, Expanding and Extending Industry-Leading Portfolio for Stem Cell …PR Newswire (press release)
Johnson & Johnson, ViaCyte Testing Possible Diabetes CureABC News

all 11 news articles »
Continue reading

2016-02-04

The Globe and Mail

Canadian ‘dream team’ to probe stem–cell link to brain cancer
The Globe and Mail
The cancer stem–cell hypothesis suggests that, over time, stem cells can accumulate a series of deleterious genetic changes that turn them into tumour-promoting cells. If so, it would explain why brain cancer can return after a tumour is removed. As …
Founder of Iowa institute shares successes with ethical stem–cell researchSt.Louis Review
Stem Cell Research Products – Opportunities, Tools, And Technologies 2016: MarketResearchReports.BizMedgadget.com (blog)
Global Stem Cell Research Products Strategic Report 2016 – Analysis, Technologies, Opportunities & Forecasts – BD …Business Wire (press release)
Broadway World –InvestorIdeas.com (press release) –SYS-CON Media (press release)
all 41 news articles »